Avista Therapeutics
Founded by Leah Byrne, PhD, Assistant Professor of Ophthalmology, Avista Therapeutics develops innovative gene therapies for retinal diseases, including rare ophthalmic conditions that have a profound impact on quality of life.
Joseph N. Martel, MD
Dr. Martel's research and clinical activities are focused on investigating and treating patients with vision-threatening vitreoretinal diseases with specific interest and expertise in vision restoration therapies, retinal prosthetic devices, and robotic-assisted vitreoretinal surgery.